Use of botulinum toxin type A in children with cerebral palsy.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Physical Therapy

• Publication date

  2006-04-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/PTJ/86.4.573PMID 16579673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Botulinum toxin in the management of cerebral palsy

  2007cited by this paper
• Botulinum toxin in the management of cerebral palsy

  2004cited by this paper
• Seminar. Cerebral palsy

  2004cited by this paper
• Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial.

  2004cited by this paper
• Clinical Effects of Botulinum Toxin A and Phenol Block on Gait in Children with Cerebral Palsy

  2004cited by this paper
• Use of botulinum toxin type A and type B for spasticity in upper and lower limbs.

  2003cited by this paper
• Measures of muscle and joint performance in the lower limb of children with cerebral palsy.

  2003cited by this paper
• The effects of botulinum toxin (BTX-A) on spasticity of the lower limb and on gait in cerebral palsy.

  2003cited by this paper
• Measures of muscle and joint performance in the lower limb of children with cerebral palsy

  2003cited by this paper
• Should we be testing and training muscle strength in cerebral palsy?

  2002cited by this paper
• Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity.

  2001cited by this paper
• Clinical Utility of Botulinum Toxin in the Treatment of Cerebral Palsy: Comprehensive Review

  2001cited by this paper
• Effects of a functional therapy program on motor abilities of children with cerebral palsy.

  2001cited by this paper
• Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.

  2000cited by this paper
• Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.

  2000cited by this paper
• Drugs Used to Treat Spasticity

  2000cited by this paper
• Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Lower Extremity Spasticity in Cerebral Palsy: A Randomized, Double-blind, Placebo-controlled Trial

  2000cited by this paper
• An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy.

  2000cited by this paper
• Biomechanical transformation of the gastroc‐soleus muscle with botulinum toxin A in children with cerebral palsy

  2000cited by this paper
• Evaluation of Botulinum Toxin A Therapy in Children With Adductor Spasm by Gross Motor Function Measure

  2000cited by this paper
• The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response

  1999cited by this paper
• Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases

  1999cited by this paper
• Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.

  1999cited by this paper
• Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment.

  1999cited by this paper
• Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy.

  1999cited by this paper
• Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A: the parents' view of functional outcome

  1999cited by this paper
• Musculoskeletal modelling in determining the effect of botulinum toxin on the hamstrings of patients with crouch gait

  1998cited by this paper
• Use of botulinum toxin injection in 17 children with spastic cerebral palsy.

  1998cited by this paper
• A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox®in the treatment of cervical dystonia

  1998cited by this paper
• Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.

  1998cited by this paper
• Development and reliability of a system to classify gross motor function in children with cerebral palsy

  1997cited by this paper
• Interventional neuropediatrics: treatment of dystonic and spastic muscular hyperactivity with botulinum toxin A.

  1997cited by this paper
• Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases.

  1997cited by this paper
• Botulinum toxin: from poison to remedy.

  1997cited by this paper
• Children undergoing treatment with botulinum toxin: The role of the physical therapist

  1997cited by this paper
• The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study.

  1997cited by this paper
• Botulinum toxin in the treatment of cerebral palsy.

  1995cited by this paper
• Effects Of Quadriceps Femoris Muscle Strengthening On Crouch Gait In Children With Spastic Diplegia

  1995cited by this paper
• Botulinum toxin A in management of cerebral palsy.

  1994cited by this paper
• BOTUNUM TOXIN A PREVENTS THE DEVELOPMENT OF CONTRACTURES IN THE HEREDITARY SPASTC MOUSE

  1994cited by this paper
• BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY

  1994cited by this paper
• Botulinum toxin A prevents the development of contractures in the hereditary spastic mouse.

  1994cited by this paper
• Management of Cerebral Palsy with Botulinum‐A Toxin: Preliminary Investigation

  1993cited by this paper
• Treatment of spasticity with botulinum toxin: A double‐blind study

  1990cited by this paper
• Interrater reliability of a modified Ashworth scale of muscle spasticity.

  1987cited by this paper
• Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.

  1987cited by this paper
• Hemifacial spasm treated with botulinum A toxin injection.

  1985cited by this paper
• Cerebral Palsy

  1983cited by this paper
• [Cerebral palsy].

  1972cited by this paper

• Botulinum Toxin Intervention in Cerebral Palsy-Induced Spasticity Management: Projected and Contradictory Effects on Skeletal Muscles

  2022cites this paper
• Psychological Stress Induced by Prone Positioning among Adults with Severe Cerebral Palsy.

  2022cites this paper
• Saccharomyces boulardii improves the behaviour and emotions of spastic cerebral palsy rats through the gut-brain axis pathway

  2021cites this paper
• The efficacy of botulinum toxin A lower limb injections in addition to physiotherapy approaches in children with cerebral palsy: A systematic review

  2019cites this paper
• Effect of Whole Body Vibration versus Suspension Therapy on Balance and Functional Capacity in Children with Diplegic Cerebral Palsy

  2019cites this paper
• Experimental Validation of the Multiphysics Modelling of Radiofrequency Ablation using Physical Phantom

  2019cites this paper
• Parálisis cerebral

  2018cites this paper
• Development of techniques for measuring the mobility of knee joints in children with Cerebral Palsy

  2018cites this paper
• Revisión sistemática de la eficacia del tratamiento combinado de fisioterapia junto con toxina botulínica tipo A en la espasticidad de miembros inferiores en niños con parálisis cerebral

  2016cites this paper
• Chapter 20 – Rehabilitation of the Child with Multiple Injuries

  2015cites this paper
• Two Different Methods of Botulnium Toxin A Injection for Releasing of Hip Adductor Spasticity in Diplegic Children

  2015cites this paper
• Impact of Aquatic Exercise Program on Muscle Tone in Spastic Hemiplegic Children with Cerebral Palsy

  2015cites this paper
• Effect of multisite botulinum toxin injections on gait quality in adults with cerebral palsy

  2014cites this paper
• Botulinum toxin A injections In Patients with Cerebral Palsy

  2014cites this paper
• The effect of the Nintendo Wii Fit on balance control and gross motor function of children with spastic hemiplegic cerebral palsy

  2013cites this paper
• Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review

  2013cites this paper
• Anwendung von Botulinumtoxin A in der Behandlung der spastischen infantilen Zerebralparese: Retrospektive klinische Beobachtungsstudie

  2012cites this paper
• [Botulinum toxin a treatment in spastic forms of cerebral palsy: a retrospective clinical study].

  2012cites this paper
• Improving quality of life of children with cerebral palsy: a systematic review of clinical trials.

  2012cites this paper
• Neurorehabilitation with versus without resistance training after botulinum toxin treatment in children with cerebral palsy: A randomized pilot study

  2012cites this paper
• Old drugs, new uses.

  2011cites this paper
• Influencia del tratamiento farmacológico de la espasticidad en la fisioterapia de la parálisis cerebral

  2010cites this paper
• Botulinum Neurotoxin: The Ugly Duckling

  2009cites this paper
• Botulinum toxin A injections do not improve surface EMG patterns during gait in children with cerebral palsy--a randomized controlled study.

  2009cites this paper
• The Effects of Functional Therapy on Motor Development in Children with Cerebral Palsy

  2009cites this paper
• Evaluation du traitement de l' equin chez l'enfant par la toxine botulique : approche multidisciplinaire au centre hospitalier d'Annecy

  2008cites this paper
• Toxina Botulínica na Paralisia Cerebral

  2007cites this paper
• Utilisation de fortes doses de toxine botulique de type A chez l'enfant: intérêt et sécurité en pratique clinique

  2007cites this paper
• BOTULINO TOKSINO IR KINEZITERAPIJOS POVEIKIS 4-7 MET Ų VAIKAMS, SERGANTIEMS CEREBRINIU PARALYéIUMI

  2007cites this paper
• Botulinum toxin type A and other factors.

  2007cites this paper
• Treatment of children with cerebral palsy.

  2007cites this paper
• Skeletal Muscle Atrophy Induced by Intramuscular Repeated Dose of Botulinum Toxin Type A in Rats

  2007cites this paper
• Botulinum toxin type A in the management of cerebral palsy: low or high dose?

  2006influential citation